What is the role of steroid-sparing agents in IBD maintenance?

• A. They are used to maintain remission while reducing steroid exposure
• B. They replace corticosteroids entirely
• C. They are only used in acute induction
• D. They have no role in IBD

Answer: (A)

The idea being tested is that steroid-sparing agents help keep the disease in check over the long term while letting you reduce or avoid corticosteroids. Steroids can quickly control inflammation, but using them chronically leads to meaningful side effects. Immunomodulators like azathioprine or 6-mercaptopurine, methotrexate in some cases, and certain biologics are used to sustain remission. By maintaining control of the disease, these agents allow tapering off steroids and minimizing their exposure, which lowers the risk of steroid-related complications. They’re used in both Crohn’s disease and ulcerative colitis and can be part of maintenance even after induction therapy. They do have a role in ongoing management, and they don’t universally replace corticosteroids in every patient, though they often reduce or eliminate the need for them over time.